Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Some patients benefit from weekly injections, while others may only need one once a month
Developed by researchers in Australia, AOD-9604 was initially investigated as a potential anti-obesity drug due to its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat accumulation)
Products tested by an independent laboratory Exclusively pure compounds without additives Worldwide Delivery Warning This product is not intended for human or veterinary use
Such conditions can prevent your body from absorbing the essential nutrient or inhibit the release of the nutrient
Sample Policy Free samples are available Contact us for information regarding our sample policy
Both AOD 9604 and tirzepatide have been through human trials, but the depth and outcome of those trials could not be more different
